Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-028846
Filing Date
2025-12-22
Accepted
2025-12-22 17:28:26
Documents
1
Period of Report
2025-12-19

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4052
  Complete submission text file 0001493152-25-028846.txt   5555
Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Issuer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4500 GREAT AMERICA PKWY STE. 100 #29 SANTA CLARA CA 95054
Business Address
Salva Francisco D. (Reporting) CIK: 0001834051 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41705 | Film No.: 251593572